Table 4 Posterior density of the measure of Regulatory Infrastructure and Good Practices

GMP requirements are published by the government (5.05.03)

1.89

0.08

(0.72)

(0.30)

MRA uses a computerized information management system (5.01.15)

1.67

0.61

(0.60)

(0.30)

Government publishes National Good Pharmacy Practice Guidelines (5.05.11)

1.50

−0.84

(0.57)

(0.31)

Government publishes National Good Distribution Practice Guidelines (5.05.07)

1.23

−0.76

(0.46)

(0.27)

An MRA exists (5.01.02)

1.20

1.34

(0.42)

(0.32)

Legal provisions establish the power and responsibilities of the MRA (5.01.01)

1.14

1.38

(0.39)

(0.31)

Whistle-blowing mechanism for the pharmaceutical sector (3.01.16)

0.95

0.04

(0.32)

(0.20)

A national medicines policy official document exists (3.01.04)

0.77

0.78

(0.28)

(0.20)

Declaration of potential conflict of interests of experts (5.02.15S)

0.75

−0.25

(0.27)

(0.18)

MRA gets funds from regular government budget (5.01.11)

0.66

0.77

(0.26)

(0.20)

Policy exists to manage and sanction conflict of interest (3.01.14)

0.56

−0.45

(0.23)

(0.17)

An assessment of the regulatory system was conducted within last five years (5.01.10)

0.51

0.56

(0.23)

(0.17)

Pharmaceutical policy implementation is being regularly monitored (3.01.12)

0.45

−0.06

(0.21)

(0.16)

MRA is a semi autonomous agency (5.01.04.02)

0.36

−0.71

(0.23)

(0.17)